Pro Medicus Ltd (ASX: PME) shares have dropped more than 20% since their peak a few weeks ago. Is this an opportunity to buy?
The station sponsors some live performances and has two shows that play recordings of concerts in the region: “WMHT Live” and ...
Wasatch International Growth Fund—Investor Class was down -7.22% but outperformed MSCI AC (All Country) World ex USA Small ...
Stockhead on MSN5d
Scott Power: ASX health stocks feel force of market volatilityMorgans analyst Scott Power notes there's a risk-off sentiment among investors as ASX health stocks fall again this week.
Prevent Blindness, the nation's leading eye health and safety nonprofit organization, has announced that Matt MacDonald, president and global head of managed care, EyeMed Vision Care, has been named ...
In a report released today, Iain Wilkie from Morgans maintained a Buy rating on Pharmaust Limited (ECQ0 – Research Report), with a price target ...
Stockhead on MSN1d
Health Check: Fantastico! Telix wins Brazilian assent for prostate cancer imaging agentBrazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.
Livewire Markets on MSN2d
Jun Bei Liu: 2 stocks for the bottom drawer and the only realistic scenarios left for 2025Investors have been rattled by volatility and trade wars. Ten Cap's Jun Bei Liu argues that the outlook hasn't changed ...
First Sentier’s David Wilson & Christian Guerra on 2025’s volatile reporting season, market surprises & top growth stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback